Search

everythinglearnresearchcommunity

for

Search:↓

Measuring minimal residual disease on day 15 helps identify high-risk leukemia patients.

Certain genetic variations in IL-16 may increase the risk of alopecia areata.

IL-26 has antimicrobial and pro-inflammatory effects in the chronic skin condition Hidradenitis Suppurativa.

Acne patients' skin, both with and without lesions, shows a strong immune response and higher antimicrobial activity.

Blocking IL-12 can help treat alopecia areata by preventing hair follicle immune issues.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

K15 staining helps distinguish basal cell carcinoma from trichoepithelioma.

IL-17-producing γδ T cells help improve bone healing.

CD8+ T cells attack hair follicle stem cells, causing scarring and hair loss.

ILC1-like cells can cause alopecia areata by themselves.

Small molecule DMF improves psoriasis and multiple sclerosis, adult skin cells can be made to grow new hair, certain skin cells initiate hair growth, IL-17C controls gut health and can cause skin inflammation, and skin cells produce IL-17 that can lead to psoriasis.

Alarmin cytokines are key in controlling skin immunity and inflammation.

Intestinal intraepithelial lymphocytes are crucial for gut immunity and maintaining the mucosal barrier.

ILC1-like cells may contribute to hair loss in alopecia areata and could be new treatment targets.

Certain immune cells, when activated by specific signals, can encourage hair growth.

Elf5 is important for skin stem cell growth and could help treat skin and hair problems.

PX-12 may help treat psoriasis by blocking inflammation and cell death.

Tph cells are linked to the severity of systemic lupus erythematosus.

A certain genetic variation in the IL1A gene may lower the risk of a hair loss condition in Chinese people.

IL-1α levels are higher in alopecia areata patients, suggesting a role in the disease.

ILC1-like cells may contribute to hair loss in alopecia areata.

Higher IL-17A and IL-23 levels are linked to alopecia areata severity and could help in tracking and treating the disease.

Higher levels of IL-1R1 and hsa-miR-19b-3p may help diagnose and predict alopecia areata severity.

Targeting MIG and MCP-1 may help treat inflammation in alopecia areata.

CD27 and IL-35 can help diagnose alopecia areata linked to bacterial infections.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Mice genetically modified to produce more Del1 protein had faster hair regrowth.

A specific RNA in cashmere goats helps improve hair growth by interacting with certain molecules.

Blocking IL-17 signaling can delay skin aging and improve skin and hair health.

IL-1 and IL-7 help activate cells that boost hair follicle stem cell growth, aiding wound healing.